Munich RE (MUV2) Q3 2025 earnings summary

Executive summary

• Net result for Q3 2025 reached €1,997m, up 120% year-over-year, with Q1-3 net result at €5.2bn, confirming the annual guidance of €6bn net result for 2025.

• Strong performance in property-casualty reinsurance and Global Specialty Insurance (GSI) due to below-average major-loss expenditure and low combined ratios.

• Life and health reinsurance faced unfavorable claims experience, but strong new business in the US and UK provided support.

• ERGO contributed €304m to net result in Q3, aided by one-off effects and strong international performance, while ERGO Germany was impacted by a negative one-off tax effect.

• Operating result for Q3 2025 was €3,036m, a significant increase from the prior year.

Financial highlights

• Insurance revenue for Q3 was €14.6bn, down from €15.5bn year-over-year, mainly due to negative currency translation effects; Q1-3 insurance revenue was €45.2bn.

• Investment result for Q3 was €2,385m, with a return of 4.1% on average market value.

• Solvency II ratio increased to 293% as of 30 September 2025, well above the target corridor.

• Combined ratio for property-casualty reinsurance in Q3 2025 was 62.7%, significantly improved from the prior year.

• ERGO net result for Q3 2025 was €304m, with international operations boosted by the consolidation of NEXT Insurance.

Outlook and guidance

• Annual net result guidance for 2025 remains at €6bn, with group insurance revenue forecast at €61bn, revised down from €62bn due to currency and premium adjustments.

• Combined ratio guidance for property-casualty reinsurance improved to around 74% (previously 79%), and for GSI to about 87% (previously 90%).

• Optimism to achieve or exceed €6bn net income for 2025, with all other expectations unchanged and guidance subject to macroeconomic and geopolitical uncertainties.

• Reserve review in Q4 may lead to further strengthening of reserves, potentially at the cost of a higher normalized combined ratio.

• ERGO insurance revenue forecast at ~€22bn, reinsurance at ~€39bn.